| 22nd week of 2021 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20210161761 | METHOD AND DEVICE FOR LOCATING A HUMAN TARGET USING SUPERFICIAL VENOUS CHARACTERISTICS | 2021-06-03 |
| 20210161762 | OBJECT-ORIENTED WEIGHT ACUPRESSURE CUSHION | 2021-06-03 |
| 20210161763 | OBJECT-DETECTING CONTAINER APPARATUS | 2021-06-03 |
| 20210161764 | PHARMACEUTICAL PACKS COMPRISING HOLOGRAPHIC LIDDING MATERIAL, AND METHOD OF MAKING THE SAME | 2021-06-03 |
| 20210161765 | Vial Stabilizer Base with Vial Adapter | 2021-06-03 |
| 20210161766 | PHARMACEUTICAL MANAGEMENT SYSTEM | 2021-06-03 |
| 20210161767 | AUTOMATIC PACKAGER FOR PHARMACEUTICALS AND METHOD OF OPERATING THE SAME | 2021-06-03 |
| 20210161768 | STORAGE CONTAINER FOR A STORAGE AND DISPENSING STATION FOR PHARMACEUTICALS | 2021-06-03 |
| 20210161769 | Smart Pack System for Medicines | 2021-06-03 |
| 20210161770 | WATER-HARDENING DENTAL CEMENT, METHOD AND KIT FOR PRODUCING THE SAME AND USE THEREOF | 2021-06-03 |
| 20210161771 | DENTAL POLYFUNCTIONAL MONOMERS AND DENTAL HYDROXYL GROUP-CONTAINING MONOMERS | 2021-06-03 |
| 20210161772 | RADICAL POLYMERISATION INITIATORS FOR LIGHT-CURABLE DENTAL MATERIALS | 2021-06-03 |
| 20210161773 | ANTIFUNGAL SOLUTION AND WIPE | 2021-06-03 |
| 20210161774 | METHOD FOR PRODUCING SOLID POWDER COSMETIC | 2021-06-03 |
| 20210161775 | WATER-RESISTANT COSMETIC COMPOSITION | 2021-06-03 |
| 20210161776 | SILICA-INCLUDING MICROCAPSULE RESIN PARTICLES, METHOD FOR PRODUCING SAME, AND APPLICATION THEREOF | 2021-06-03 |
| 20210161777 | METHODS OF MAKING SILVER NANOPARTICLES AND THEIR APPLICATIONS | 2021-06-03 |
| 20210161778 | STABILIZED STANNOUS COMPOSITIONS | 2021-06-03 |
| 20210161779 | Hand Sanitizing Compositions | 2021-06-03 |
| 20210161780 | HAIR CONDITIONER COMPOSITIONS WITH A PRESERVATIVE SYSTEM CONTAINING SODIUM BENZOATE AND GLYCOLS AND/OR GLYCERYL ESTERS | 2021-06-03 |
| 20210161781 | Cosmetic Compositions | 2021-06-03 |
| 20210161782 | ORAL CARE COMPOSITIONS | 2021-06-03 |
| 20210161783 | USE OF SPECIFIC BENZYLIDENE MALONATES FOR PROTECTING THE SKIN FROM CHEMICALLY INDUCED STRESS | 2021-06-03 |
| 20210161784 | HAIR CONDITIONER COMPOSITIONS CONTAINING BEHENAMIDOPROPYL DIMETHYLAMINE | 2021-06-03 |
| 20210161785 | Method of Preventing Both Caries and Periodontal Disease Simultaneously in One Procedure | 2021-06-03 |
| 20210161786 | N-ACYL SARCOSINES AS ANTIMICROBIALS FOR PRESERVATION OF HOME AND PERSONAL CARE PRODUCTS | 2021-06-03 |
| 20210161787 | CONCENTRATED PERSONAL CLEANSING COMPOSITIONS AND METHODS | 2021-06-03 |
| 20210161788 | Anti-Blue Light Dermal Topical Composition and Applications Thereof | 2021-06-03 |
| 20210161789 | HETEROCYCLIC-DITHIOL CLICK CHEMISTRY | 2021-06-03 |
| 20210161790 | Process for treating hair | 2021-06-03 |
| 20210161791 | PARTICULATE COMPOSITION COMPRISING CRYSTALLINE ALPHA, ALPHA-TREHALOSE DIHYDRATE, ITS PREPARATION AND USES | 2021-06-03 |
| 20210161792 | COSMETIC COMPOSITION FOR KERATIN FIBRES | 2021-06-03 |
| 20210161793 | TOPICAL COMPOSITION | 2021-06-03 |
| 20210161794 | SILICONE ALTERNATIVES | 2021-06-03 |
| 20210161795 | THICKENING AND STABILISING SYSTEM OF NATURAL ORIGIN SUITABLE, IN PARTICULAR, FOR PREPARING COSMETIC PRODUCTS | 2021-06-03 |
| 20210161796 | HIGH MOLECULAR WEIGHT ESTHETIC COMPOSITIONS | 2021-06-03 |
| 20210161797 | COSMETIC COMPOSITION COMPRISING A HYPERBRANCHED COPOLYMER AND A HAIR STYLING POLYMER | 2021-06-03 |
| 20210161798 | COSMETIC COMPOSITION COMPRISING EXOSOMES DERIVED FROM GALACTOMYCES AS ACTIVE INGREDIENT | 2021-06-03 |
| 20210161799 | THERAPEUTIC OIL COMPOSITION FOR SHAVING | 2021-06-03 |
| 20210161800 | COMPOSITIONS FOR TREATMENT OF XEROSTOMIA AND FOR TOOTH TREATMENT | 2021-06-03 |
| 20210161801 | SKIN CARE FILM BASED ON BIOFIBER | 2021-06-03 |
| 20210161802 | Oral Delivery System and Method | 2021-06-03 |
| 20210161803 | EFFERVESCENT TABLETS THAT INCLUDE CRYSTALLINE SUGAR BINDER AND METHODS OF MAKING THE SAME | 2021-06-03 |
| 20210161804 | FLUTICASONE AND VILANTEROL FORMULATION AND INHALER | 2021-06-03 |
| 20210161805 | Delivery Capsule with Threshold Release | 2021-06-03 |
| 20210161806 | Octreotide Depot Formulation with Constantly High Exposure Levels | 2021-06-03 |
| 20210161807 | IMPLANTABLE DEVICE FOR LOCALIZED DRUG DELIVERY, USES AND MANUFACTURING METHOD THEREOF | 2021-06-03 |
| 20210161808 | Nasal Drug Delivery System of Brivaracetam or Salt Thereof | 2021-06-03 |
| 20210161809 | BIODEGRADABLE ALPHA-2 AGONIST POLYMERIC IMPLANTS AND THERAPEUTIC USES THEREOF | 2021-06-03 |
| 20210161810 | Pharmaceutical Compositions Including Low Dosages of Desmopressin | 2021-06-03 |
| 20210161811 | SOFT, CHEWABLE AND ORALLY DISSOLVABLE AND/OR DISINTEGRABLE PRODUCTS | 2021-06-03 |
| 20210161812 | NANOCRYSTAL MICROPARTICLES OF POORLY SOLUBLE DRUGS AND METHODS OF PRODUCTION AND USE THEREOF | 2021-06-03 |
| 20210161813 | COMESTIBLE COMPOSITIONS FOR PROMOTING ATP SYNTHESIS | 2021-06-03 |
| 20210161814 | CRYOGEL SCAFFOLD CAPABLE OF CONTROLLING DEGREE OF DEGRADATION AND SOFT BIO-INTEGRATED DEVICE IN WHICH DRUG MODULATING IMMUNOSUPPRESSIVE ACTION IN SOLID MICROENVIRONMENT IS LOADED IN SAME SCAFFOLD | 2021-06-03 |
| 20210161815 | Dosing Regimens for Treatment of Proliferative Disorders | 2021-06-03 |
| 20210161816 | METHODS AND COMPOSITIONS FOR TREATING SKIN AFFLICTIONS | 2021-06-03 |
| 20210161817 | THERAPEUTIC AGENTS SPECIFICALLY DELIVERED BY EXOSOMES FOR CANCER TREATMENT | 2021-06-03 |
| 20210161818 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | 2021-06-03 |
| 20210161819 | METHOD OF ENCAPSULATING ACTIVE INGREDIENTS IN LIPOSOMES | 2021-06-03 |
| 20210161820 | GRANULATION COMPOSITION | 2021-06-03 |
| 20210161821 | FREEZE-DRIED FORMULATIONS OF ANTIBACTERIAL PROTEIN | 2021-06-03 |
| 20210161822 | ORAL COMPOSITIONS COMPRISING METHYLPREDNISOLONE SODIUM SUCCINATE | 2021-06-03 |
| 20210161823 | SOLID ORAL DOSAGE FORMS OF ESLICARBAZEPINE | 2021-06-03 |
| 20210161824 | ORALLY DISINTEGRATING TABLETS COMPRISING GLYCOPYRROLATE AND METHODS FOR INCREASING BIOAVAILABILITY | 2021-06-03 |
| 20210161825 | CHLOROQUINE-BASED MATERIALS FOR THE TREATMENT OF DISEASES | 2021-06-03 |
| 20210161826 | BIODEGRADABLE POLYMER FORMULATIONS FOR EXTENDED EFFICACY OF BOTULINUM TOXIN | 2021-06-03 |
| 20210161827 | TASTE-MASKED PHARMACEUTICAL COMPOSITIONS WITH GASTROSOLUBLE PORE-FORMERS | 2021-06-03 |
| 20210161828 | NANOCAPSULES COMPRISING MODIFIED NUCLEOBASES AND/OR NUCLEOSIDES, HYDROGELS AND OLEOGELS COMPRISING THEM AND USES THEREOF | 2021-06-03 |
| 20210161829 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | 2021-06-03 |
| 20210161830 | ACTIVE SUBSTANCE CARRIER COMPRISING BIOPOLYMER | 2021-06-03 |
| 20210161831 | GOLD NANO-DELIVERY SYSTEM FOR PAIN AND CANCER THERAPY | 2021-06-03 |
| 20210161832 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF SOLIFENACIN | 2021-06-03 |
| 20210161833 | COMPOSITIONS AND METHODS FOR REGULATING THE ENCOCANNABINOID SYSTEM | 2021-06-03 |
| 20210161834 | CURCUMIN-BASED COMPOSITIONS & METHODS OF USE THEREOF | 2021-06-03 |
| 20210161836 | TREATMENT OF DEMYELINATING DISORDERS | 2021-06-03 |
| 20210161837 | METHODS FOR TREATING CANCER WITH RORGAMMA INHIBITORS | 2021-06-03 |
| 20210161838 | Oral Pharmaceutical Formulations of Bitter Compounds for Asthma | 2021-06-03 |
| 20210161839 | METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT | 2021-06-03 |
| 20210161840 | COMPOSITIONS AND METHODS FOR TREATMENT OF IRON OVERLOAD | 2021-06-03 |
| 20210161841 | FORMULATION FOR TREATING CHRONIC WOUNDS | 2021-06-03 |
| 20210161842 | ABSCISIC ACID FOR THE TREATMENT OF SKIN DISEASES | 2021-06-03 |
| 20210161843 | PHARMACEUTICAL COMPOSITIONS OF FLURBIPROFEN AND 5-HT1 - RECEPTOR AGONISTS | 2021-06-03 |
| 20210161844 | COMPOSITIONS CONTAINING TUCARESOL OR ITS ANALOGS | 2021-06-03 |
| 20210161845 | METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS | 2021-06-03 |
| 20210161846 | A STABLE PHARMACEUTICAL COMPOSITION COMPRISING PENICILLAMINE | 2021-06-03 |
| 20210161847 | METHOD OF TREATMENT FOR REDUCING PAIN SENSITIZATION | 2021-06-03 |
| 20210161848 | METHODS AND COMPOSITIONS RELATING TO LIPOKINES FOR TREATING METABOLIC DISORDERS | 2021-06-03 |
| 20210161849 | STORAGE STABLE MIXTURES, METHOD OF IMPROVING RETENTION OF A COMPOUND AND USE OF RICE HULLS AND/OR RICE BRAN TO ENHANCE RETENTION OF A COMPOUND | 2021-06-03 |
| 20210161850 | USE OF KETONE ESTERS FOR PREVENTION OF CNS OXYGEN TOXICITY | 2021-06-03 |
| 20210161851 | COMBINATION THERAPY OF LYMPHOMA | 2021-06-03 |
| 20210161852 | FUMARATE ESTER DOSAGE FORMS | 2021-06-03 |
| 20210161853 | POLYUNSATURATED FATTY ACID MONOGLYCERIDES, COMPOSITIONS, METHODS AND USES THEREOF | 2021-06-03 |
| 20210161854 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2021-06-03 |
| 20210161855 | 5-LIPOXYGENASE ANTAGONISTS | 2021-06-03 |
| 20210161856 | L-THEANINE AND TETRAHYDROCANNABINOL FORMULATION | 2021-06-03 |
| 20210161857 | COMPOSITION AND METHOD FOR SUPPRESSING INCREASE IN BLOOD GLUCOSE LEVEL | 2021-06-03 |
| 20210161858 | COMPOSITION FOR PREVENTING AND TREATING MUSCLE DISEASE, IMPROVING MUSCLE FUNCTION OR ENHANCING MOTOR PERFORMANCE COMPRISING HYDRANGENOL OR HYDRANGEA EXTRACT AS ACTIVE INGREDIENT | 2021-06-03 |
| 20210161859 | USE OF CXCR4 ANTAGONISTS | 2021-06-03 |
| 20210161860 | IMMUNOSUPPRESSANT FORMULATION | 2021-06-03 |
| 20210161861 | USE OF METHADONE METABOLITES FOR TREATMENT OF ANXIETY AND DEPRESSION | 2021-06-03 |
